Lung neoplasm malignant and Squamous cell carcinoma

Summary:

Squamous cell carcinoma is found among people with Lung neoplasm malignant, especially for people who are female, 40-49 old.

The study analyzes which people have Squamous cell carcinoma with Lung neoplasm malignant. It is created by eHealthMe based on reports of 28 people who have Lung neoplasm malignant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Lung neoplasm malignant?

Lung neoplasm malignant (cancer tumour of lung) is found to be associated with 1,149 drugs and 926 conditions by eHealthMe. Check the latest studies of Lung neoplasm malignant.

What is Squamous cell carcinoma?

Squamous cell carcinoma (a cancer of a kind of epithelial cell) is found to be associated with 814 drugs and 895 conditions by eHealthMe. Check the latest studies of Squamous cell carcinoma.



On Jul, 16, 2026

28 people who have Lung Neoplasm Malignant and Squamous Cell Carcinoma are studied.

Would you have Squamous cell carcinoma when you have Lung neoplasm malignant?

Gender of people who have Lung Neoplasm Malignant and experienced Squamous Cell Carcinoma *:

  • female: 64 %
  • male: 36 %

Age of people who have Lung Neoplasm Malignant and experienced Squamous Cell Carcinoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 58.82 %
  • 50-59: 11.76 %
  • 60+: 29.41 %

Common co-existing conditions for these people *:

  1. Osteoporosis (bones weak and more likely to break): 2 people, 7.14%
  2. Skin Cancer: 1 person, 3.57%
  3. Pain: 1 person, 3.57%
  4. Hiv Infection: 1 person, 3.57%
  5. Dumping Syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight): 1 person, 3.57%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.57%
  7. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 3.57%

Common drugs taken by these people *:

  1. Digoxin: 3 people, 10.71%
  2. Halcion: 3 people, 10.71%
  3. Gemzar: 3 people, 10.71%
  4. Fentanyl: 2 people, 7.14%
  5. Fosamax: 2 people, 7.14%
  6. Klonopin: 2 people, 7.14%
  7. Xalkori: 2 people, 7.14%
  8. Vfend: 2 people, 7.14%
  9. Glucosamine: 1 person, 3.57%
  10. Gilotrif: 1 person, 3.57%

Common symptoms for these people *:

  1. Laryngeal Cancer Stage Iii (cancer may have spread to lymph node on same side): 12 people, 42.86%
  2. Leukopenia (less number of white blood cells in blood): 12 people, 42.86%
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 42.86%
  4. Lung Carcinoma Cell Type Unspecified Stage Iii (the lung cancer has spread to nearby tissue or too far away lymph nodes): 12 people, 42.86%
  5. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 12 people, 42.86%
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 14.29%
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 4 people, 14.29%
  8. Delirium (wild excitement): 3 people, 10.71%
  9. Interstitial Lung Disease: 3 people, 10.71%
  10. Malignant Neoplasm Progression (cancer tumour came back): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Squamous cell carcinoma?

- Check whether Squamous cell carcinoma is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Squamous cell carcinoma:

All the conditions that are associated with Squamous cell carcinoma:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Squamous cell carcinoma and Lung neoplasm malignant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: